vimarsana.com

Integer (NYSE:ITGR – Get Free Report)‘s stock had its “buy” rating restated by stock analysts at Benchmark in a research note issued to investors on Friday, Benzinga reports. They currently have a $130.00 price target on the medical equipment provider’s stock. Benchmark’s target price points to a potential upside of 19.74% from the company’s previous […]

Related Keywords

Arizona ,United States ,Costa Rica ,Puerto Rico ,America , ,Keycorp ,Janney Montgomery Scott ,Integer Company Profile ,Cornercap Investment Counsel Inc ,Integer Holdings Corporation ,Quadrant Capital Group ,Get Free Report ,Trading Down ,Investment Counsel ,State Retirement System ,Capital Group ,Montgomery Scott ,Holdings Corporation ,Integer Daily ,Integer ,Nyse Itgr ,Itgr ,Medical ,39153l10 ,Reiterated Rating ,Benchmark Co ,

© 2025 Vimarsana

vimarsana.com © 2020. All Rights Reserved.